MAGEA1
MAGEA1 (MAGE family member A1, also known as MAGE1, CT1.1 and MGC9326) is a member of the MAGEA family and encodes melanoma-associated antigen 1. It was identified as an antigen recognised on a melanoma by autologous cytolytic T-lymphocytes, and it may act in transcriptional regulation. Browse Assay Genie's current range of MAGEA1 research reagents below, or read on for the biology behind the target.
MAGEA1 may be involved in transcriptional regulation. According to UniProt, it may interact with SNW1 and recruit the histone deacetylase HDAC1, and it may inhibit transactivation by the notch intracellular domain (NICD). It may also play a role in embryonal development and in tumour transformation or aspects of tumour progression. The protein is annotated as an antigen recognised on a melanoma by autologous cytolytic T-lymphocytes, which is the origin of its name.
The MAGEA1 gene belongs to the MAGEA gene family, whose members encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes vary considerably. This suggests that the existence of the family allows the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered on the X chromosome at Xq28. The MAGEA1 protein is found in the cytoplasm and the nucleus, which fits with a proposed role in gene regulation. Researchers studying the MAGEA1 protein often compare it with other MAGEA members such as MAGEA2, MAGEA3 and MAGEA4.
The HGNC previous names for this gene, melanoma antigen family A, 1 (directs expression of antigen MZ2-E) and melanoma antigen family A1, reflect its discovery as a tumour antigen. NCBI Gene notes that MAGEA genes have been implicated in some hereditary disorders, such as dyskeratosis congenita.
MAGEA1 is an antigen recognised on a melanoma by autologous cytolytic T-lymphocytes, making it a reference point for studies of T-cell recognition of tumours.
MAGEA1 may interact with SNW1 and recruit HDAC1, so it is studied in work on histone deacetylation and transcriptional control.
MAGEA1 may inhibit transactivation by the notch intracellular domain (NICD), linking it to research on how Notch output is modulated.
MAGEA1 may play a role in embryonal development, tumour transformation and aspects of tumour progression.
MAGEA1 may be involved in transcriptional regulation through interaction with SNW1 and recruitment of HDAC1, and it may inhibit NICD transactivation. It may also play a role in embryonal development and tumour progression. It is also an antigen recognised by cytolytic T-lymphocytes on melanoma.
MAGEA1 is also called MAGE1, CT1.1 and MGC9326. The HGNC full name is MAGE family member A1, and UniProt calls the protein melanoma-associated antigen 1. Earlier HGNC names referred to melanoma antigen family A1 and to antigen MZ2-E.
MAGEA1 is one of a family of MAGEA genes clustered at Xq28. Members encode proteins with 50 to 80% sequence identity, but their promoters and first exons vary. Orthologue data for mouse and rat are not given here; check the datasheet of any product for its validated reactivity.
Other MAGEA family members that share sequence identity with MAGEA1 and are studied as tumour-associated antigens.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43355; product specifications from Assay Genie datasheets.